| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.021 | 0.9 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.018 | 0.9 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |